Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
590 Leser
Artikel bewerten:
(2)

Ron Kilgarlin of American Screening LLC Presents Inclusive Options for Urine and Saliva Drug Tests

Finanznachrichten News

SHREVEPORT, LA / ACCESSWIRE / March 2, 2021 / American Screening LLC has been supporting the efforts to combat substance abuse and addiction for almost 17 years. The organization did this by providing a wide range of drug testing products and by trying to offer the best possible prices without compromising quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading distributors of diagnostic products and essential medical supplies, making it a trusted partner to clinics, laboratories, medical practices, probation officers, staffing companies, and consumers. Over the years, American Screening LLC has been steadily expanding its inventory to include screening solutions for various conditions and substances, personal protective equipment (PPE), and everyday health products, but it has always remained firmly focused on stocking the best merchandise. A source of pride for the company is its extensive range of urine and saliva drug tests, which are the two most commonly administered varieties due to being the most accurate and least invasive.

"The opioid crisis in the United States has brought the problem of substance abuse into the limelight, uniting the nation in a fight against drug misuse. Apart from the heavy personal toll, alcohol and drug abuse (nicotine included) costs the US economy dearly: according to the Surgeon General, it cuts the national GDP by more than $740 billion annually through crime, lost work productivity, and health care," American Screening LLC notes. "Reducing drug misuse and addiction requires a combination of robust preventive programs, increased public awareness, strong oversight of the prescription medicines market, and extensive screening in all settings. Our company is a vital player in the last area, ensuring that accurate and affordable tests are readily available to any interested party."

American Screening LLC offers more than 80 products in the saliva testing category, covering the range from general screening for unknown substances to identifying specific drugs. Accurate, fast, and reliable, its oral fluid kits can detect the most commonly abused substances, including alcohol, amphetamines, barbiturates, cocaine, marijuana, and opiates. Many of the products are carried at reduced prices for bulk orders, which makes American Screening LLC a great partner for large clinics and medical practices. The company is also a leading supplier of urine drug tests, offering kits that enable screening at home, in work environments, and law enforcement settings. Fast and easy to use, these tests have up to 99% accuracy in detecting a long list of illicit or commonly abused substances, among them fentanyl, oxycodone, marijuana (THC), cocaine, opiates, methamphetamine, ETG, K2, amphetamines, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, tramadol, and ecstasy (MDMA). Whether looking for urine cassettes, cups, dip cards, or key cups, buyers are certain to find the right product for their needs, benefiting from attractive prices and the highest quality of customer service.

American Screening LLC is one of only a handful of companies awarded certification under the Medical Device Single Audit Program (MDSAP), which designates it as compliant with the quality management requirements of numerous jurisdictions. Established in 2004 by Ron Kilgarlin, American Screening LLC has grown from a home-based operation into one of the leading providers of diagnostic tests and medical supplies to the United States, South America, Asia, Africa, Europe, and Australia.

American Screening, LLC - Leading Provider of Diagnostic Tests & Medical Supplies: http://americanscreeningcorporationnews.com

American Screening Corporation Enables Speedy and Efficient Decision-Making with Vast Selection of Rapid Drug Tests: https://news.yahoo.com/news/american-screening-corporation-enables-speedy-000000586.html

American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/

Contact Information:
Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening, LLC



View source version on accesswire.com:
https://www.accesswire.com/633088/Ron-Kilgarlin-of-American-Screening-LLC-Presents-Inclusive-Options-for-Urine-and-Saliva-Drug-Tests

© 2021 ACCESSWIRE
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.